"West-Drog" Sp. z o.o. Oddzial W Polsce (Poland)

Main Activities: Highway, Street, and Bridge Construction

Secondary Activities: Residential Building Construction | Nonresidential Building Construction | Other Heavy and Civil Engineering Construction | Other Building Equipment Contractors | Other Building Finishing Contractors | Lumber, Plywood, Millwork, and Wood Panel Merchant Wholesalers | Support Activities for Road Transportation | Automotive Equipment Rental and Leasing | Passenger Car Rental and Leasing

Full name: "West-Drog" Sp. z o.o. Oddzial W Polsce

Profile Updated: June 27, 2025

"West-Drog" Sp. z o.o. Oddzial W Polsce is a company in Poland, with a head office in Lubojenka. The company operates in the Highway, Street, and Bridge Construction sector. It was established on June 20, 2022. The latest financial highlights indicate a net sales revenue increase of 487.38% in 2025. Its total assets decreased by 9.23% over the same period. The net profit margin of "West-Drog" Sp. z o.o. Oddzial W Polsce decreased by 1.17% in 2025.

Headquarters
Ul. Prosta 88/90
Lubojenka; Slaskie; Postal Code: 42-209

Contact Details: Purchase the "West-Drog" Sp. z o.o. Oddzial W Polsce report to view the information.

Basic Information

Financial Auditors:

Purchase the "West-Drog" Sp. z o.o. Oddzial W Polsce report to view the information.

Incorporation Date:

June 20, 2022

Key Executives

Purchase this report to view the information.

Director

Purchase this report to view the information.

Power of Attorney

Company Performance

Financial values in the chart are available after "West-Drog" Sp. z o.o. Oddzial W Polsce report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

487.38%▲

Total Operating Revenue

592.55%▲

Operating Profit

347.09%▲

EBITDA

233.6%▲

Net Profit/Loss for the Period

356.37%▲

Total Assets

-9.23%▼

Total Equity

456.37%▲

Operating Profit Margin

-1.83%▼

Net Profit Margin

-1.17%▼

Return on Equity (ROE)

-17.97%▼

Quick Ratio

0.51%▲

Similar companies

Related EMIS Industry Reports